Î¥ÏÎ¿ÏÏÎ³Î¹ÎºÎ® Î±ÏÏÏÎ±ÏÎ·

More documents

Recommendations

Info

19152 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) L - ATC / . DDD MON L01XX G4 - / ( ) L01XX02 ASPARAGINASE L01XX02 A 2263001 01 L-ASPARAGINASE 10.000/MLY.PD.INJ 10.000U/VIAL BTx5 VIALS MEDAC GESELLSCH 14000 U 3.571 140.6469 502.25 502.25 L01XX G5 - / ( ) L01XX08 PENTOSTATIN L01XX08 P 0824901 01 NIPENT PD.INJ.SOL 10MG/VIAL BTx1 VIAL HOSPIRA UK LIMITE 0.00049 G 20.231 36.8543 745.60 745.60 L02 -E L02A -O L02AB - ( ) L02AB01 MEGESTROL ACETATE L02AB01 M 1771703 01 MEGACE TAB 160MG/TAB BT x 30( blister BRISTOL-MYERS SQ 0.16 G 30.000 0.6187 18.56 18.56 L02AE -A L02AE01 BUSERELIN ACETATE L02AE01 B 1913904 01 SUPREFACT DEPOT 2 IMPLANT 6,3MG/PF.SYR BT x 1 PF.SYR SANOFI-AVENTIS AE 0.00011 G 57.273 2.9323 167.94 167.94 L02AE01 B 1913905 01 SUPREFACT DEPOT 3 IMPLANT 9.45MG/PF.SYR BTx1PF.SYR SANOFI-AVENTIS AE 0.00011 G 85.909 3.0227 259.68 259.68 L02AE02 LEUPRORELIN ACETATE L02AE02 L 2981002 01 PROSTAPLANT IMPLANT 5MG/IMPLANT BTx1BAGx(1IMP SANDOZ GMBH, KUN 5.6E-05 G 90.000 2.5787 232.08 232.08 L02AE02 L 2981001 01 PROSTAPLANT IMPLANT 3,6MG/IMPLANT BTx1BAGx(1IMP SANDOZ GMBH, KUN 0.00012 G 30.000 2.9847 89.54 89.54 L02AE03 GOSERELINE ACETATE L02AE03 G 1962901 01 ZOLADEX INJ.IMPL 3.6 MG/PF.SYR BTx1 PF.SYR. +S ASTRAZENECA A.E. 0.00013 G 27.907 3.4909 97.42 87.47 L02AE03 G 1962902 01 ZOLADEX INJ.IMPL 10,8MG/PF.SYR. BTx1PF.SYR. +S ASTRAZENECA A.E. 0.00013 G 83.721 3.2375 271.05 262.42
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 19153 L - ATC / . DDD MON ( ) L02AE02 LEUPRORELIN ACETATE L02AE02 L 1927602 01 DARONDA DEPOT PS.INJ.SUS 3,75MG/VIAL BTx1VIAL+1 AMP ABBVIE 0.00013 G 27.985 2.6554 74.31 71.20 L02AE02 L 1927604 01 DARONDA DEPOT PS.INJ.SUS 11,25MG/VIAL BTx1 ABBVIE 0.00013 G 83.955 2.4724 207.57 207.57 L02AE02 L 1997001 02 ELITYRAN PS.INJ.SUS 3,75MG/VIALPF BTx 1 PF.SYR + VIANEX A.E. 0.00013 G 27.985 2.9444 82.40 71.20 L02AE02 L 1997002 03 ELITYRAN PS.INJ.SUS 11,25MG/VIALP BT x 1 PF.SYR + VIANEX A.E. 0.00013 G 83.955 2.6247 220.36 213.61 L02AE02 L 2704401 01 LEUPROL PS.INJ.SUS 3,75MG/VIAL : 0.00013 G 27.985 2.2251 62.27 62.27 L02AE02 L 2704402 01 LEUPROL PS.INJ.SUS 11,25MG/VIAL : 0.00013 G 83.955 2.5477 213.89 213.61 L02AE04 TRIPTORELINE L02AE04 T 1960801 02 ARVEKAP PS.INJ.SUS 3,75MG/VIAL BTxVIAL+1AMP S IPSEN 0.00013 G 27.985 3.5976 100.68 71.20 L02AE04 T 1960803 02 ARVEKAP PS.INJ.SUS 11,25MG/VIAL BTx1VIAL+1AMP IPSEN 0.00013 G 83.955 2.9385 246.70 213.61 L02AE04 T 2524201 01 GONAPEPTYL DEPOT PD.S.IN.SR 3,75MG/PF BTx1PFS+1PFS FERRING . 0.00013 G 27.985 4.2712 119.53 71.20 ( ) L02AE01 BUSERELIN ACETATE L02AE01 B 1913902 02 SUPREFACT INJ.SOL 1MG/ML BT x 2 VIALS x 7 SANOFI-AVENTIS AE 0.0015 G 9.333 2.1579 20.14 20.14 L02AE02 LEUPRORELIN ACETATE L02AE02 L 1927601 01 DARONDA INJ.SOL 14MG/2,8ML VIA BTx1 VIALx2,8 M ABBVIE 0.001 G 14.000 6.5414 91.58 83.18 L02AE04 TRIPTORELINE L02AE04 T 1960802 01 ARVEKAP LY.PD.INJ 0,1MG/VIAL BT x 7 VIALS x 0 IPSEN 1 TE 7.000 4.6857 32.80 32.80 L02AE04 T 2524202 01 GONAPEPTYL DAILY INJ.SOL 0,1MG/1ML PF.S BTx7 (PF.SYR. x FERRING . 1 TE 7.000 6.2029 43.42 41.59 ( ) L02AE01 BUSERELIN ACETATE L02AE01 B 1913901 01 SUPREFACT M.D.NAS.SP 100MCG/DOSE BT x 4 FL x100 D SANOFI-AVENTIS AE 0.0012 G 33.333 2.2728 75.76 75.76 L02B -A L02BA -A- ( ) L02BA01 TAMOXIFEN CITRATE L02BA01 T 2412602 01 ADIFEN TAB 20MG/TAB BTx30(BLIST 3x1 MEDICAMERC A.E. 0.02 G 30.000 0.1720 5.16 5.16
Page 1 and 2:
18959 ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥ
Page 3 and 4:
ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡ
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144: ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡ
Page 193: ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡ
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 271 and 272:
Page 273 and 274:
Page 275 and 276:
Page 277 and 278:
Page 279 and 280:
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295 and 296:
Page 297 and 298:
Page 299 and 300:
Page 301 and 302:
Page 303 and 304:
Page 305 and 306:
Page 307 and 308:
Page 309 and 310:
Page 311 and 312:
Page 313 and 314:
Page 315 and 316:
Page 317 and 318:
Page 319 and 320:
Page 321 and 322:
Page 323 and 324:
Page 325 and 326:
Page 327 and 328:
Page 329 and 330:
Page 331 and 332:
Page 333 and 334:
Page 335 and 336:
Page 337 and 338:
Page 339 and 340:
Page 341 and 342:
Page 343 and 344:
show all

Î¥ÏÎ¿Ï ÏÎ³Î¹ÎºÎ® Î±ÏÏÏÎ±ÏÎ·

Create successful ePaper yourself

Delete template?

Save as template?

Î¥ÏÎ¿ÏÏÎ³Î¹ÎºÎ® Î±ÏÏÏÎ±ÏÎ·